UroGen Pharma Ltd Newsroom

D. Boral Capital Maintains Buy on UroGen Pharma, Maintains $25 Price Target

BenzingaDec 6 20:17

UroGen Pharma Analyst Ratings

BenzingaDec 6 20:16

TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $35

Futu NewsNov 7 04:31

UroGen Pharma Analyst Ratings

BenzingaNov 7 00:21

Correction to UroGen Pharma Rating

Dow JonesOct 30 05:58

UroGen Pharma Price Target Maintained With a $25.00/Share by EF Hutton

Dow JonesOct 29 19:32

TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating

Futu NewsOct 16 20:31

Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40

Futu NewsOct 16 20:31

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

Futu NewsOct 16 18:31

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

Futu NewsOct 14 20:35

UroGen Pharma Analyst Ratings

BenzingaOct 14 20:12

EF Hutton Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $25

Futu NewsOct 14 19:31

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

Futu NewsOct 3 18:31

Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40

Futu NewsSep 18 20:33

UroGen Pharma Analyst Ratings

BenzingaAug 22 19:52

Guggenheim Initiates UroGen Pharma at Buy With $40 Price Target

MT NewswiresAug 22 19:38

Guggenheim Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $40

Futu NewsAug 22 18:31

UroGen Pharma Analyst Ratings

BenzingaAug 16 00:49

HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $60 Price Target

BenzingaAug 16 00:49

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60

Futu NewsAug 15 21:31